Arrowhead Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,353,719

Value ($000)

89,873

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	89,873	0.0%	1,353,719	12/31/2025
2025 Q3	11/10/2025	46,419	0.0%	1,345,860	9/30/2025
2025 Q2	8/12/2025	18,498	0.0%	1,170,745	6/30/2025
2025 Q1	9/15/2025	13,190	0.0%	1,035,290	3/31/2025
2024 Q4	2/6/2025	19,133	0.0%	1,017,720	12/31/2024
2024 Q3	11/12/2024	19,504	0.0%	1,006,935	9/30/2024
2024 Q2	8/12/2024	25,843	0.0%	994,361	6/30/2024
2024 Q1	5/9/2024	28,135	0.0%	983,755	3/31/2024
2023 Q4	2/6/2024	25,887	0.0%	845,979	12/31/2023
2023 Q3	11/8/2023	22,705	0.0%	844,985	9/30/2023
2023 Q2	8/10/2023	40,833	0.0%	1,145,059	6/30/2023
2023 Q1	5/12/2023	29,402	0.0%	1,157,575	3/31/2023
2022 Q4	2/13/2023	46,175	0.0%	1,138,443	12/31/2022
2022 Q3	11/14/2022	36,486	0.0%	1,103,943	9/30/2022
2022 Q2	8/15/2022	37,988	0.0%	1,078,888	6/30/2022
2022 Q1	5/13/2022	49,933	0.0%	1,085,723	3/31/2022
2021 Q4	2/11/2022	69,608	0.0%	1,049,894	12/31/2021
2021 Q3	11/16/2021	64,350	0.0%	1,030,753	9/30/2021
2021 Q2	8/16/2021	83,371	0.0%	1,006,645	6/30/2021
2021 Q1	5/17/2021	63,681	0.0%	960,347	3/31/2021
2020 Q4	2/16/2021	71,167	0.0%	927,495	12/31/2020
2020 Q3	11/13/2020	39,388	0.0%	914,717	9/30/2020
2020 Q2	8/20/2020	31,508	0.0%	729,508	6/30/2020
2020 Q1	5/15/2020	20,227	0.0%	703,026	3/31/2020
2019 Q4	2/7/2020	39,902	0.0%	629,061	12/31/2019